Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma Meeting Abstract
| Authors: | Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; Malin, H.; Neha, K.; Alexander, M. L.; Sham, M.; Urvi, A. S.; Carlyn, R. T.; Saad, Z. U.; Giralt, S. A. |
| Abstract Title: | Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma |
| Meeting Title: | 2023 Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2023 Mar 16-18 |
| Meeting Location: | Fukuoka, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-11-01 |
| Start Page: | S1427 |
| End Page: | S1428 |
| Language: | English |
| ACCESSION: | WOS:001106690100253 |
| DOI: | 10.1016/j.annonc.2023.09.279 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: MO50-4 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
